Sanofi announced positive results from the pivotal Phase 3 LIBERTY-AFRS-AIMS trial showing Dupixent significantly improved outcomes for adults and children aged 6 years and older with allergic fungal ...

Novavax on Thursday provided preliminary adjusted revenue for 2026 and pushed back its profitability target by a year to 2028 ...

Sanofi has cited security concerns about planned highrises near its plant, while the developer says the provincial order ...

Sanofi Consumer Healthcare India Limited said on Thursday that its third-quarter profit jumped 40% to ₹62.9 crore and revenue ...

Accenture, Sanofi, and Dell Technologies stand out in today's top analyst research picks, each navigating growth and market ...

A recently launched campaign starring patients and scientists shows Sanofi in hot pursuit of scientific innovation. | A ...

Sanofi Consumer Healthcare India (SCHIL) soared 8.47% to Rs 5,052 after the company reported a strong performance for the quarter ended 30 September 2025.

Sanofi's “Badge of Honor,” made with FCB Health New York, won gold for Data-Driven Campaign of the Year among suppliers, ...

Sanofi’s ‘A Trusted Circle,’ made with Republica Havas Health, won bronze for Purpose-led Campaign of the Year among ...

In November 2025, SOE Medical Procurement of Ukraine renegotiated the managed entry agreements (MEAs) with the international ...

A new Merck pill called enlicitide slashes levels of harmful LDL cholesterol by up to 60%, similar to injectable PCSK9 drugs ...

The project will expand Boryung’s oral penicillin antibiotic production line at its campus in Ansan, South Korea, from 2,777 ...